BeOne Medicines (ONC) Depreciation and Depletion (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Depreciation and Depletion of $39.4 million for Q1 2026, up 24.58% year-over-year from $31.6 million in Q1 2025, and up 14.43% quarter-over-quarter from $34.4 million in Q4 2025.
BeOne Medicines (ONC) Depreciation and Depletion (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Depreciation and Depletion for 12 consecutive years, with $39.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation and Depletion rose 24.58% year-over-year to $39.4 million; the TTM figure through Mar 2026 stood at $139.4 million (down 20.1% YoY), while the FY2025 annual figure was $131.6 million, down 21.16% from the prior year.
- Depreciation and Depletion grew to $39.4 million in Q1 2026 per ONC's latest filing, from $34.4 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $70.0 million in Q3 2024 and bottomed at $14.5 million in Q2 2022.
- Historically, Depreciation and Depletion has averaged $28.3 million across 5 years, with a median of $23.8 million in 2024.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion soared 263.93% — and 2025, when it slumped 48.98%.
- BeOne Medicines' Depreciation and Depletion stood at $17.0 million in 2022, then increased by 22.38% to $20.9 million in 2023, then jumped by 135.1% to $49.0 million in 2024, then retreated by 29.83% to $34.4 million in 2025, then grew by 14.43% to $39.4 million in 2026.
- Business Quant data shows ONC's Depreciation and Depletion at $39.4 million in Q1 2026, $34.4 million in Q4 2025, and $35.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.91 Mn |
| Jun 30, 2026 | 38.91 Mn |
| Mar 31, 2026 | 39.39 Mn |
| Mar 31, 2026 | 39.39 Mn |
| Dec 31, 2025 | 34.42 Mn |
| Dec 31, 2025 | 34.42 Mn |
| Sep 30, 2025 | 35.73 Mn |
| Sep 30, 2025 | 35.73 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Mar 31, 2025 | 31.61 Mn |
| Mar 31, 2025 | 31.61 Mn |
| Dec 31, 2024 | 49.05 Mn |
| Dec 31, 2024 | 49.05 Mn |
| Sep 30, 2024 | 70.03 Mn |
| Sep 30, 2024 | 70.03 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Mar 31, 2024 | 24.11 Mn |
| Mar 31, 2024 | 24.11 Mn |